SENSIDOSE AB

sensidose-ab-logo

Sensidose AB has development of drug dosage for microdosage of active substance in order to provide an individualized dose. MyFID is the first smart dosing device for tablets. By combining the possibilities of a modern smart phone technology and โ€œmicro" - tablets an improved and better usage of medicines can be achieved. MyFID is pre-programmed to deliver a certain amount of medicine at a certain time. The physician decides which dose a patient should use and when it should be taken. However... in order for the device not to rule the patientโ€™s life, care has been taken to ensure that the patients have the freedom to control the functions of the device. MyFID has unique registration capabilities. It registers the amount and time a dose is delivered. MyFID will ask and record reasons why a dose is taken. It also records disease symptoms using easy to use scales that allows for the patient and the doctor to follow treatment effects, to get a continuous picture of how the disease evolves and fluctuates with time. All information recorded is available for both the patient and the physician, and can be retrieved using a specially developed inbuilt standardized treatment report. MyFID therefore gives the physician and the patient a more precise and correct background for further treatment decisions.

#SimilarOrganizations #People #Financial #Website #More

SENSIDOSE AB

Industry:
Health Care Hospital Medical Device

Founded:
1998-01-01

Address:
Uppsala, Uppsala Lan, Sweden

Country:
Sweden

Website Url:
http://www.sensidose.se

Total Employee:
1+

Status:
Active

Contact:
+4610 - 70 77 380

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Global Site Tag Mobile Non Scaleable Content


Similar Organizations

metrasens-logo

Metrasens

Metrasens develops, markets, and installs medical devices that improve safety in hospitals.

vlpbio-logo

VLPbio

VLPbio focuses on research and development of chimeric virus like particles (VLPs) as vaccines in animal and human health.

Current Employees Featured

roger-svensson_image

Roger Svensson
Roger Svensson Marketing Manager @ Sensidose AB
Marketing Manager

alf-malmberg_image

Alf Malmberg
Alf Malmberg Head of QA @ Sensidose AB
Head of QA

jack-spira_image

Jack Spira
Jack Spira CEO @ Sensidose AB
CEO

Investors List

almi-invest_image

Almi Invest

Almi Invest investment in Venture Round - Sensidose AB

uppsala-innovation-centre_image

Uppsala Innovation Centre

Uppsala Innovation Centre investment in Venture Round - Sensidose AB

Official Site Inspections

http://www.sensidose.se Semrush global rank: 4.5 M Semrush visits lastest month: 929

  • Host name: linux378.unoeuro.com
  • IP address: 185.20.205.54
  • Location: Denmark
  • Latitude: 55.7123
  • Longitude: 12.0564
  • Timezone: Europe/Copenhagen

Loading ...

More informations about "Sensidose AB" on Search Engine